[CAS NO. 887375-67-9]  Ripasudil (K-115) hydrochloride dihydrate

Ships within Stock Price Qty Total
$0.00
$0.00
Please click "REQUEST A QUOTE" button if you need other sizes or custom synthesis
request a quote
If there is no stock, or you need other sizes or custom synthesis, please:

PRODUCTS SPECIFICATIONS [887375-67-9]

Store
Catalog
SLK-S7995
Brand
Selleck
CAS
887375-67-9

DESCRIPTION [887375-67-9]

Overview

MDLMFCD26960897
Molecular Weight395.88
Molecular FormulaC15H18FN3O2S.Cl H.2 H2 O
SMILESO=S(C1=CC=CC2=C1C(F)=CN=C2)(N3[C@@H](C)CNCCC3)=O.[H]O[H].[H]O[H].[H]Cl

For research use only.

Storage

3 years,-20°C,powder
1 years,-80°C,in solvent

Shipping

Room temperature shipping(Stability testing shows this product can be shipped without any cooling measures.)

Preparing Stock Solutions

1 mg5 mg10 mg
1 mM2.5260 mL12.6301 mL25.2602 mL
5 mM0.5052 mL2.5260 mL5.0520 mL
10 mM0.2526 mL1.2630 mL2.5260 mL
50 mM0.0505 mL0.2526 mL0.5052 mL

Description

Ripasudil (K-115) hydrochloride dihydrate is potent inhibitor with of 51 nM and 19 nM for ROCK1 and ROCK2, respectively, used for the treatment of glaucoma and ocular hypertension.

Targets

ROCK2 [1]
(Cell-free assay)
ROCK1 [1]
(Cell-free assay)
19 nM51 nM

In vitro

In monkey trabecular meshwork (TM) cells, Ripasudil induces retraction and rounding of cell bodies as well as disruption of actin bundles. In Schlemm's canal endothelial (SCE) cells, Ripasudil significantly decreases transendothelial electrical resistance (TEER), increases the transendothelial flux of FITC-dextran, and disrupts cellular localization of ZO-1 expression.